HUTCHMED (China) Limited (HCM)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

264.00p
   
  • Change Today:
    -9.50p
  • 52 Week High: 325.00p
  • 52 Week Low: 189.00p
  • Currency: UK Pounds
  • Shares Issued: 872.11m
  • Volume: 8,546
  • Market Cap: £2,302.37m
  • RiskGrade: 226
  • Beta: 0.03

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
92.04% below the market average92.04% below the market average92.04% below the market average92.04% below the market average92.04% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
1yr Revenue Growth
83.72% below the market average83.72% below the market average83.72% below the market average83.72% below the market average83.72% below the market average
79.31% below the sector average79.31% below the sector average79.31% below the sector average79.31% below the sector average79.31% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
70.88% below the market average70.88% below the market average70.88% below the market average70.88% below the market average70.88% below the market average
13.51% below the sector average13.51% below the sector average13.51% below the sector average13.51% below the sector average13.51% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
87.42% above the market average87.42% above the market average87.42% above the market average87.42% above the market average87.42% above the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average
Price Chg 3m
48.61% above the market average48.61% above the market average48.61% above the market average48.61% above the market average48.61% above the market average
42.22% above the sector average42.22% above the sector average42.22% above the sector average42.22% above the sector average42.22% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
66.03% above the market average66.03% above the market average66.03% above the market average66.03% above the market average66.03% above the market average
51.22% above the sector average51.22% above the sector average51.22% above the sector average51.22% above the sector average51.22% above the sector average
Momentum 20
86.41% above the market average86.41% above the market average86.41% above the market average86.41% above the market average86.41% above the market average
80.49% above the sector average80.49% above the sector average80.49% above the sector average80.49% above the sector average80.49% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
11.3% below the market average11.3% below the market average11.3% below the market average11.3% below the market average11.3% below the market average
46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
7.00% above the market average7.00% above the market average7.00% above the market average7.00% above the market average7.00% above the market average
63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
56.95% above the market average56.95% above the market average56.95% above the market average56.95% above the market average56.95% above the market average
73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average
Operating Profit Loss
51.38% above the market average51.38% above the market average51.38% above the market average51.38% above the market average51.38% above the market average
86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
76.33% above the market average76.33% above the market average76.33% above the market average76.33% above the market average76.33% above the market average
85.37% above the sector average85.37% above the sector average85.37% above the sector average85.37% above the sector average85.37% above the sector average
Cash
69.34% above the market average69.34% above the market average69.34% above the market average69.34% above the market average69.34% above the market average
76.74% above the sector average76.74% above the sector average76.74% above the sector average76.74% above the sector average76.74% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HCM Market Data

Currency UK Pounds
Share Price 264.00p
Change Today -9.50p
% Change -3.47 %
52 Week High 325.00p
52 Week Low 189.00p
Volume 8,546
Shares Issued 872.11m
Market Cap £2,302.37m
Beta 0.03
RiskGrade 226

HCM Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
46.12% below the market average46.12% below the market average46.12% below the market average46.12% below the market average46.12% below the market average
34.88% below the sector average34.88% below the sector average34.88% below the sector average34.88% below the sector average34.88% below the sector average
Price Trend
66.13% above the market average66.13% above the market average66.13% above the market average66.13% above the market average66.13% above the market average
68.89% above the sector average68.89% above the sector average68.89% above the sector average68.89% above the sector average68.89% above the sector average
Income Not Available
Growth
43.62% below the market average43.62% below the market average43.62% below the market average43.62% below the market average43.62% below the market average
86.67% below the sector average86.67% below the sector average86.67% below the sector average86.67% below the sector average86.67% below the sector average

HCM Dividends

No dividends found

Trades for 01-Aug-2025

Time Volume / Share Price
16:35 13 @ 264.00p
16:35 12 @ 264.00p
16:35 1 @ 264.00p
15:55 1 @ 255.35p
15:22 11 @ 260.60p

HCM Key Personnel

Chair Dan Eldar
CEO Weiguo Su

Top of Page